Kurs & Likviditet
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Bioteknik |
2023-10-02 14:49:40
Reference is made to section 4.1 of Oslo Rulebook II, Issuer Rules, and the
requirement to have a stock price of minimum NOK 1 per share. At the Company's
extraordinary general meeting held on 27 September 2023, it was resolved to
perform a reverse share split in the ratio 30:1 (the "Reverse Share Split"),
i.e. that 30 Shares in the Company, each with a nominal value of NOK 0.10 is
combined into one Share, each with a nominal value of NOK 3, and a subsequent
share capital decrease reducing the nominal value per Share from NOK 3 to NOK
0.60 per Share.
To have the total number of shares in the Company divisible by 30 in the Reverse
Share Split, the general meeting resolved that the share capital is increased by
the issuance of a number of shares that results in the total number of shares in
the Company being divisible by 30, i.e., by issuance of seven (7) new shares
(the "New Shares"). Digman AS, a company controlled by CEO Erik Digman Wiklund,
subscribed for the New Shares.
The share capital increase resulting from the issue of the New Shares have today
been registered with the Norwegian Register of Business Enterprises, and the
Company's new share capital after the share capital increase and the reverse
share split is NOK 4 298 245,80 divided into 7,163,743 shares, each with a
nominal value of NOK 0.60.
For further information, please contact:
Erik Digman Wiklund, CEO
Phone: +47 413 33 536
Email: erik.wiklund@circio.com (erik.wiklund@targovax.com)
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: renate.birkeli@circio.com (renate.birkeli@targovax.com)